7 Results
New Leaders Take Center Stage at Advisory Council Meeting in January
Funding News Edition: February 21, 2024
This was the first meeting at which NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council. It was also the first time that guest speaker Dr. Monica Bertagnolli, NIH Director, addressed our Council.

Long COVID and the RECOVER-TLC Initiative
Funding News Edition: November 6, 2024
Long COVID’s broad and varied effects on diverse populations demand new clinical approaches and fewer restrictions to inclusion and access to achieve breakthrough results.

News Briefs and Worth Repeating
Funding News Edition: October 16, 2024
With Gratitude to Dr. Hugh Auchincloss, and a Welcome to Dr. Sarah Read; Newcomer to NIH Funding? Attend the NIH Grants Process Primer Webinar; OLAW Annual Reports Are Due on December 1; Loan Repayment Program Application Deadline Is November 21
Take Note of Reissued Investigator-Initiated Clinical Trial NOFOs
Funding News Edition: February 7, 2024
The NIAID Clinical Trial Implementation Cooperative Agreement notice of funding opportunity (NOFO) is designed for high-risk trials. The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement NOFO allows small business concerns to proposed investigator-initiated clinical trials.
Examining NIAID’s R01 and R21 Application and Award Counts for FY 2023
Funding News Edition: March 6, 2024
We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year as well as the number of grants NIAID awarded. To add context, we present the data alongside the same figures for the preceding 4 years.

Tabulating NIAID’s R01 and R21 Application and Award Counts for FY 2024
Funding News Edition: December 18, 2024
Each year, we share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year as well as the number of grants NIAID awarded.

Happenings from the September Meeting of NIAID’s Advisory Council
Funding News Edition: October 2, 2024
NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council, as did Dr. Ted Piersen, Director of NIAID’s Vaccine Research Center.

Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.